Versigent (NYSE:VGNT) Director Kevin Clark Sells 74,130 Shares

Versigent (NYSE:VGNTGet Free Report) Director Kevin Clark sold 74,130 shares of the business’s stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $45.67, for a total value of $3,385,517.10. Following the transaction, the director directly owned 124,849 shares of the company’s stock, valued at $5,701,853.83. This represents a 37.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Versigent Stock Up 1.6%

Shares of NYSE:VGNT opened at $46.45 on Friday. The firm’s 50 day simple moving average is $44.28. Versigent has a twelve month low of $26.34 and a twelve month high of $50.88. The company has a market cap of $3.29 billion and a P/E ratio of 24.19. The company has a debt-to-equity ratio of 7.29, a quick ratio of 1.09 and a current ratio of 1.40.

Versigent (NYSE:VGNTGet Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $1.92 EPS for the quarter, topping the consensus estimate of $1.58 by $0.34. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.29 billion. Analysts anticipate that Versigent will post 7.23 EPS for the current year.

Versigent Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 18th. Stockholders of record on Friday, September 4th will be paid a $0.13 dividend. The ex-dividend date is Friday, September 4th. This represents a $0.52 annualized dividend and a dividend yield of 1.1%.

Analysts Set New Price Targets

VGNT has been the subject of several research analyst reports. Zacks Research cut shares of Versigent from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $54.00 price target on shares of Versigent in a research report on Wednesday, August 5th. Oppenheimer set a $50.00 price objective on shares of Versigent in a report on Tuesday, July 21st. Argus increased their target price on shares of Versigent from $50.00 to $54.00 and gave the company a “buy” rating in a research note on Thursday, August 13th. Finally, Royal Bank Of Canada upgraded shares of Versigent from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $41.00 to $52.00 in a research note on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $54.00.

Get Our Latest Analysis on VGNT

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Integrated Wealth Concepts LLC acquired a new stake in Versigent during the second quarter worth $57,000. Sequoia Financial Advisors LLC bought a new stake in Versigent in the 2nd quarter valued at $220,000. Kintegral Advisory LLC acquired a new position in shares of Versigent in the 2nd quarter valued at $224,000. Engineers Gate Manager LP acquired a new position in shares of Versigent in the 2nd quarter valued at $418,000. Finally, Corient Private Wealth LP bought a new position in shares of Versigent during the 2nd quarter worth about $426,000.

Versigent Company Profile

(Get Free Report)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.

Further Reading

Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.